July 24, 2017 2:48 AM ET


Company Overview of Peloton Therapeutics, Inc.

Key Executives for Peloton Therapeutics, Inc.

NameBoard RelationshipsTitleAge
John A. Josey Ph.D.No RelationshipsChief Executive Officer56
Michael S. Brown M.D.35 RelationshipsFounder and Director76
Steven L. McKnight Ph.D.53 RelationshipsFounder and SAB Chairman67
Michael F. Haller Ph.D.No RelationshipsChief Business Officer--
Mohammad Hirmand M.D.No RelationshipsChief Medical Officer47

Peloton Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael S. Brown M.D. 35 RelationshipsPeloton Therapeutics, Inc.76
Steven L. McKnight Ph.D. 53 RelationshipsMirna Therapeutics, Inc.67
Timothy W. Kutzkey Ph.D. 20 RelationshipsNeurona Therapeutics Inc.--
David V. Goeddel Ph.D. 73 RelationshipsThe Column Group LLC65
Brett A. Ringle J.D. 8 RelationshipsRemeditex Ventures, LLC--
View All Board Members

Peloton Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Steven L. McKnight53 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Peloton Therapeutics, Inc. CEO Compensation
Industry Average


Torrent Pharmaceuticals Limited Announces Resignation of Ashish Nanda, Independent Director
July 22, 2017 10:03 AM ET
Yichang Hec Changjiang Pharmaceutical Co., Ltd. Receives Resignation Letter by Ms. Xue Lian, Employee Representative Supervisor
July 22, 2017 12:00 AM ET
Reviva Pharmaceuticals Appoints Bradley Thompson to its Board of Directors
July 21, 2017 9:15 PM ET
GlaxoSmithKline PLC Appoints Laurie Glimcher to the Board as Non-Executive Director, Effective September 1, 2017
July 21, 2017 10:00 AM ET
Novartis Pharmaceuticals Corporation Announce Acceptance of US Food and Drug Administration to Review Biologics License Application (Bla) for AMG 334
July 20, 2017 8:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Peloton Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.